Skip to main content
Clinical Trials/NCT02473666
NCT02473666
Completed
Not Applicable

Patient Blood Management - Use and Outcome

University of Zurich1 site in 1 country250,000 target enrollmentJanuary 2012
ConditionsHemorrhage

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hemorrhage
Sponsor
University of Zurich
Enrollment
250000
Locations
1
Primary Endpoint
Percentage of transfusions per participant
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Study the influence of transfusion related Patient Blood Management Program actions on transfusion-related outcome measures and cost.

Detailed Description

At the University Hospital of Zurich, an in-house designed monitoring and feedback system was introduced which electronically registers each transfusion of any allogeneic blood product, be it red blood cells, plasma or platelets as well as corresponding laboratory data. Results are reported quarterly to Department heads. The investigator analyzes whether the introduction of this monitoring and feedback system as part of a patient blood management Program has a significant influence on use of allogeneic blood product transfusions and transfusion-related costs, without compromising patient outcome.

Registry
clinicaltrials.gov
Start Date
January 2012
End Date
December 2019
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Only case records, all discharged patients of the University Hospital of Zürich

Exclusion Criteria

  • Not discharged from our Hospital.

Outcomes

Primary Outcomes

Percentage of transfusions per participant

Time Frame: participants will be followed form date of hospital entry until date of discharge or date of death up to 3 years

Participant wich had transfusion will be identified and the administrative, financial and clinical data will be compared to participants without transfusions

Secondary Outcomes

  • Cost of any blood product per participant(participants will be followed form date of hospital entry until date of discharge or date of death up to 3 years)
  • Percentage of transfusion of any blood product per participant(participants will be followed form date of hospital entry until date of discharge or date of death up to 3 years)
  • Survey of Patient Blood Management System(participants will be followed form date of hospital entry until date of discharge or date of death up to 3 years)

Study Sites (1)

Loading locations...

Similar Trials